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Abstract
Background/Aim. Primary therapeutic approach to lum-
bar ureteral stones is still contraversial. The aim of the study
was to investigate the influence of stone impaction and size
on the effectiveness of proximal ureteral stone lithotripsy.
Methods. A total of 123 patients with proximal ureteral
stones were investigated in this prospective study perfor-
med in a 10- month period. The patients were divided into
the group I – 86 patients treated with extracorporeal shock
wave lithotripsy (ESWL) and the group II – 37 patients tre-
ated with “Swiss” Lithoclast. In the group I, 49 stones
(57%) were classified as impacted, while 20 stones (23.3%)
were larger than 100  mm2. In the group II, 26 stones
(70.3%) were impacted, and 11 stones (29.7%) were larger
than 100 mm2. Stones were defined as impacted by the ra-
diographic, echosonographic as well as endoscopic findings
in the group II of patients. Stone size was presented in
mm2. Chemical composition of stones were almost the sa-
me in both groups of the patients. Results. Generally, there
was no statistically significant difference in the treatment
success between the groups. However, stones larger than
100 mm2 were statistically more successfully treated
endoscopically, while there was no statistical difference in
the treatment success of impacted stones between these two
groups. Conclusion. ESWL can by considered as primary
first therapeutic approach in treatment of all proximal urete-
ral stones except for stones larger than 100 mm2 that should
primarily be treated endoscopically.
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Apstrakt
Uvod/Cilj. Primarni pristup u lečenju kamena uretera i
danas je predmet naučnih kontroverzi naročito kad je u pi-
tanju lokalizacija kamena u proksimalnom delu uretera. Cilj
rada bio je da se ispita uticaj inklavisanosti i veličine kamena
na efikasnost dezintegrativnih metoda lečenja kod te lokali-
zacije u ureteru. Metode. U 10-mesečnoj prospektivnoj
studiji ispitana su 123 bolesnika sa kamenom u proksimal-
nom delu uretera. U zavisnosti od primenjene metode dez-
integracije bolesnici su bili podeljeni u grupu I  –  86
bolesnika tretiranih ekstrakorporalnom udarnotalasnom li-
totripsijom (ESWL) kod kojih je dokazana inklavisanost 49
kalkulusa (57,0%), a površina kamena bila je veća od
100 mm2 kod 20 kalkulusa (23,3%) i grupu II – 37 bolesnika
kod kojih je primenjena endoskopska litotripsija aparatom
„Swiss“ Lithoclast, kod kojih je inklavisanost konstatovana
kod 26 kalkulusa (70,3%), a površina veća od 100 mm2 kod
11 kalkulusa (29,7%). Procena inklavisanosti kalkulusa
vršena je na osnovu ehosonografskog, radiografskog, a u II
grupi i endoskopskog nalaza. U obe grupe bolesnika hemi-
jski sastav kamena bio je identičan. Rezultati. U pogledu
efikasnosti dezintegracije kamena nije bilo statistički znača-
jne razlike između ESWL i Lithoclasta. Kod površine
kamena veće od 100 mm2 značajno bolji rezultati postignuti
su primenom endoskopske dezintegracije, dok inklavisanost
kamena nije uticala statistički značajno na rezultate ni u jed-
noj grupi bolesnika. Zaključak. Metoda ESWL može se
smatrati primarnom metodom izbora u lečenju kamena
proksimalnog dela uretera, osim onih čija je površina veća
od 100 mm2 koje bi primarno trebalo tretirati endoskopski.
Ključne reči:
urolitijaza; kamenci, ureteralni; lečenje; litotripsija;
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Introduction
Extracorporeal shock wave lithotripsy (ESWL) and ure-
teroscopic lithotriptors developed in the last two decades of the
20th century represent a revolution in urology and lead to
modern era – an era of minimally invasive therapy of ureteric
stones. Before 1992 ESWL was considered to be the first
therapeutic choice for ureteral stones in all parts of ureter.
Later studies, however, revealed better results of distal ureteral
stones treatment by ureteroscopic approach 
1, 2. Till now
ESWL has been considered as first treatment option for lum-
bar ureteral stones because of lower complications rate and
auxiliary procedures rate, comparing to ureteroscopic treat-
ment. The question of first therapeutic approach to ureteral
stone removal is still contraversial expecially for stones lo-
cated in the proximal part of ureter. Large number of investi-
gators did not find significant difference in treatment success
between ESWL and ureteroscopy, regarding proximal ureteral
stone localization
 3–8. Beside that, some authors reported even
better results of proximal ureteral stone treatment with uretero-
scopic lithotripsy than with ESWL 
9–11. For these reasons,
there is a certain need to investigate which factors have influ-
ence on proximal ureteral stones lithotripsy effectiveness, as
well as what would be the first therapeutic choice.
So, the aim of our study was to investigate the influence
of stone impaction and size on proximal ureteral stones
lithotripsy effectiveness.
Methods
A total of 123 patients with proximal ureteral stones
were investigated in this prospective study performed in a 10
months period. Patients were divided in the group I – 86 pa-
tients treated with ESWL (Siemens Lithostar, Germany) and
the group II  –  37 patients treated ureteroscopically with
“Swiss” Lithoclast (EMS, Switzerland). Indications for treat-
ment were also the same in both groups of the patients: stone
size 7  mm with probability of spontaneous elimination less
than 20%, or the absence of spontaneous stone elimination in a
more than 30-day period of clinical evolution, with standard
stone visualization diagnostic procedures performed (echo-
sonography, kidneys, ureters and bladder radiography – KUB,
intravenous urography). In the group I 49 stones (57.0%) were
classified as impacted, and 20 stones (23.3%) were larger than
100 mm
2. In the group II 26 stones (70.3%) were impacted,
and 11 stones (29.7%) larger than 100 mm
2. Stone were de-
fined as impacted by the following diagnostic criteria: persis-
tent or worsened hydronephrosis on successive echosono-
grams (Figure 1) or contrast radiograms (Figure 2) and by en-
doscopic findings such as edema and ureteral mucosa inflam-
mation around and distal of stone impaction. Stone size was
presented in mm
2.
Lithotripsy efficiency was estimated by echosonogra-
phy and KUB performed 10–14 days after the procedure in
the group I, immediately or one day after the procedure in
the group II and after three monts in both groups of the pa-
tients. Statistical difference of obtained data was analysed by
χ
2 test.
Fig. 1 – Urinary tract echosonogram: marked right
hydronephrosis caused by impacted and bulky (21 mm in
diameter) proximal ureteric stone
Fig. 2 – Radiographic appearance of impacted proximal ure-
teric stone: marked uretero-hydronephrosis caused by
10 × 7 mm large stone, with no contrast visualization distal
of stone impaction on intravenous urogram (framed area)
Results
There was no difference in distribution of patients re-
garding age and male/female ratio. The group I of patients
consisted of 51 men, age 25–77 (average 53.1) years and 35
women, age 18–80 (average 50.2) years. The group II of pa-
tients consisted of 27 men, age 17–76 (average 49.3) years
and 10 women, age 29–74 (average 51.8) years. Chemical
composition of stones were investigated by X-ray diffraction
and were almost the same in both groups of the patients, with
predominance of calcium-oxalate in more than 60% of the
cases. Calcium-oxalate monohydrate was predominant in
more than 50% of calcium-oxalate stones.
Stone impaction was analized in Table 1. There were no
statistical difference in the number of impacted stones be-
tween the groups I and II (χ
2 = 1.921, p > 0.05).Volumen 66, Broj 2 VOJNOSANITETSKI PREGLED Strana 131
Radulović S, et al. Vojnosanit Pregl 2009; 66(2): 129–133.
Table 1
Proximal ureteric stone impaction in patients treated with
extracorporeal shock wave lithotripsy (group I) and
“Swiss” Lithoclast (group II)
Number (%) of patients Impacted stone group I group II
No 37 (43%) 11 (29.7%)
Yes 49 (57%) 26 (70.3%)
Total 86 (100.0%) 37 (100.0%)
In the group I stone size varied from 16 to 275 (aver-
agely 82.8) mm
2 with stones larger than 100 mm
2 in 23.3%
of cases. In the group II stone size varied from 15 to 275 (av-
eragely 86.7) mm
2, with stones larger than 100 mm
2 regis-
trated in 29.7% of patients. Analysis of data from Table 2
showed no statistical difference in the number of stones
larger than 100 mm
2 between the two groups of the patients
(χ
2 = 0.575, p > 0.05).
There were no significant difference in disintegration
success between the two groups (χ
2 = 0.235, p > 0.05) (Table
3). Success was defined as the abscence of stone fragments
on KUB peformed up to three months after the treatment.
Partial success was defined as the presence of fragments,
smaller than stone burden before lithotripsy, even three
months after the procedure. The presence of stone unchanged
size after procedure was defined as unsucces.
In spite of procentual superiority of ballistic lithotripsy
to ESWL regarding the number of successful procedures as
shown in Table 4, statistical analysis, however, revealed no
significant difference between the two groups of patients in
impacted proximal ureteral stone treatment success
(χ
2 = 2.605, p > 0.05).
Unlike stone impaction, analysis of influence of stone
size on lithotripsy success showed that proximal ureteral
stones larger than 100 mm
2 were significantly more success-
fully treated with Lithoclast than with ESWL (χ
2 = 4.045,
p < 0.05) (Table 5).
Table 2
Proximal ureteric stone quadrature in patients treated with
extracorporeal shock wave lithotripsy (group I) and
“Swiss” Lithoclast (group II)
Number (%) of patients Stone quadrature group I group II
Smaller than 100mm
2 66 (76.7%) 26 (70.3%)
Larger than 100mm
2 20 (23.3%) 11 (29.7%)
Total 86 (100.0%) 37 (100.0%)
Table 3
Lithotripsy effectiveness in patients treated with
extracorporeal shock wave lithotripsy (group I) and
“Swiss” Lithoclast (group II)
Number (%) of patients Lithotripsy effectiveness group I group II
Success 59 (68.6%) 27 (73.0%)
Partial success and failure 27 (31.4%) 10 (27.0%)
Total 86 100.0%) 37 100.0%)
Table 4
Impacted stones lithotripsy effectiveness in patients treated
with extracorporeal shock wave lithotripsy (group I) and
“Swiss” Lithoclast (group II)
 Number (%) of patients Lithotripsy effectiveness group I group II
Success  26 (53.1%)  19 (73.1%)
Partial success  10 (20.4%)  2 (7.7%)
Failure  13 (26.5%)  5 (19.2%)
Total  49 (100.0%)  26 (100.0%)
Table 5
Lithotripsy effectiveness of stones larger than 100 mm
2 in
patients treated with extracorporeal shock wave lithotripsy
(group I) and “Swiss” Lithoclast (group II)
 Number (%) of patients Lithotripsy effectiveness group I group II
Success  7 (35.0%)  8 (72.7%)
Partial success  5 (25.0%)
Failure  8 (40.0%)  3 (27.3%)
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Discussion
Advancements in medical technology for urolithiasis
treatment mode after 1980 brought significant advantages.
Comparing to ureterolithotomy, ESWL and ureteroscopic
procedures are minimally invasive therapeutic approaches
for those ureteral stones that cannot be eliminated spontane-
ously due to their size or degree of impaction either. The ad-
vantages of these two therapeutic approaches are well
known: possibility of treatment in analgesia or analgoseda-
tion and consequently in outpatient unit, less frequent intra-
as well as postoperative complications and less working in-
ability of patients. In order to make ureteric stone treatment
more efficient and rational, question of gold therapeutic
standard – primary therapeutic choice, is arising. Having in
mind similar success rate of ESWL and uretoscopic proce-
dures, ESWL was considered favorable for proximal ureteral
stones treatment due to lower complication rate comparing to
ureteroscopic treatment. Additionally, there are many reports
demonstrating that retrograde stone propulsion during proce-
dure is the most common cause of unsuccessful endoscopic
treatment. Reported success for ureteral stone treatment was
from 71%, with 28.9% retrograde propulsion of stone frag-
ments 
12, to 100%, but with retrograde fragment propulsions
registrated in 48% of cases 
13. Percentage of retrograde stone
propulsion varied from just 5.5% 
14, to even 60% 
15. In such
cases additional ESWL treatment was necessary. In our
study endoscopic lithotripsy of proximal ureteral stones was
successful in 73% of cases with 21.6% retrograde stone pro-
pulsions. Puppo et al. 
9 reported the success of 93.6% re-
gardless stone localization and recommended ballistic litho-
tripsy with “Swiss” Lithoclast as first therapeutic options for
all ureteral stones.
In our study ESWL was successful in 68.6% of the
cases. Gonzales et al. 
4 on the other side reported 97% suc-
cessful ESWL procedures in their study. Regarding per-
centage of “stone free” outcomes, large numbers of authors
emphasize stone size, stone impaction and chemical struc-
ture as the most important factors influencing ESWL suc-
cess 
4, 16.
Based on the results obtained comparing ESWL with
Modulith SL20 device and “Swiss” Lithoclast treatment of
ureteral stones, Eden et al. 
10 concluded that ESWL is opti-
mal treatment for stone size below 8 mm, while for stones
larger than 8 mm and multiple stones Lithoclast should be
first therapeutic option. Eden’s attitude was also confirmed
by other authors 
4, 17–21. Kim et al. 
22 achieved cumulative
“stone free” status with Siemens Lithostar: 100% for stone
smaller than 5 mm, 90% for stones 6–10 mm, 87% for stones
11–15 mm, 70% for stones 16–20 mm, 67% for stones 21–
25 mm and only 50% for stones larger than 25 mm and thus
concluded that ureteral stone size has very important influ-
ence on ESWL outcome (p < 0.01). Our study also confirms
the results of Kim’s 
22 study, by 72.7% success rate for
Lithoclast lithotripsy comparing to only 35% success ac-
complished with ESWL for ureteral stones larger than
100 mm
2 (p < 0.05).
One of the factors that can influence ureteral stone
minimally invasive treatment outcome is stone impaction.
Dretler and Weinstein 
23 reported in 1988 the opinion that
impacted ureteral stone should be primarily treated endoso-
pically. Later reports 
24, 25 confirmed the opinion of Yagisawa
et al. 
26 too, by 91% successful pneumatic ureteroscopic
lithotripsies of impacted ureteral stones and only 9% failed
lithotripsies due to retrograde stone propulsion or sharp ure-
teric curve below a stone site. By other authors attitudes 
27,
the best therapeutic effect in cases of impacted stone can be
achieved by stone pushing back from ureter to kidney and
than its ESWL treatment. On the other side, Srivastava et al.
28 achieved 93% successful results by in situ ESWL treat-
ment of no impacted ureteral stones and only 35% successful
results in impacted stones group. Kim et al. 
22 also confirmed
a high influence of ureteral stone impaction on ESWL out-
come. In their study, ESWL of ureteral stones was 100%
successful in no obstructed ureter, 80% successful in mild
obstructed ureter and only 50% successful in completely ob-
structed ureter (defined as an absence of contrast excretion
from obstructed kidney). Other authors, however, consider
that ESWL of impacted stone in ureter is a therapeutic
method of choice, but not in cases of high degree of stone
impaction in whom previous urine drainage is indicated 
11.
For such cases ureteroscopic lithotripsy should be primarily
performed. Statistical analysis of our study, in spite of 73%
successful Lithoclast lithotripsies and 53% successful ESWL
treatments, did not confirm a significant influence of stone
impaction on ESWL and Lithoclast treatment success. The
results of our study are at least statistically consonant with
Sinha’s et al. 
29 results by which ESWL of impacted and no
impacted ureteral stones were equally successful – in 76.7%
of cases (stones were defined as impacted in cases of no
visualization of contrast distal of stone site). Among factors
that influence ESWL successfulness, such are stone impac-
tion, localization, number of stones, first ESWL session fail-
ure and patient sex, age and obesity, stone size and distal
ureteral stone localization alone have the strongest negative
influence on ESWL treatment outcome 
16, 19.
Conclusion
The results of our study showed no statistically signifi-
cant difference between “Swiss” Lithoclast and ESWL in
proximal ureteral stones treatment. Evaluation of stone im-
paction and stone size influence on treatment success showed
significantly more efficient treatment of proximal ureteral
stones larger than 100 mm
2 with Lithoclast, while stone im-
paction had no influence on the tretament efficiency differ-
ence between two methods. Based on these results, ESWL
should be considered as first therapeutic approach for all
proximal ureteral stones, except for stones larger than
100 mm
2 that should be primarily treated endoscopically.Volumen 66, Broj 2 VOJNOSANITETSKI PREGLED Strana 133
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